Raymond James & Associates’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-6,004
Closed -$380K 4240
2021
Q1
$380K Sell
6,004
-813
-12% -$37.3K ﹤0.01% 3207
2020
Q4
$229K Buy
+6,817
New +$201K ﹤0.01% 3299

Other funds holding MORF

Raymond James & Associates's MORF Position: Q2 2021 in Review

Raymond James & Associates sold out of Morphic Holding, Inc. Common Stock (MORF) in Q2 2021, closing a stake of 6,004 shares — an estimated $380K sold.

Raymond James & Associates first reported a position in MORF in Q4 2020 and held it in 2 quarters. The position peaked at $380K in Q1 2021. 106 funds tracked by Wall St. Rank hold MORF as of Q2 2021.

  • Raymond James & Associates reported no remaining Morphic Holding, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Raymond James & Associates sold 6,004 Morphic Holding, Inc. Common Stock shares in Q2 2021, an estimated $380K.
  • Raymond James & Associates first reported a position in Morphic Holding, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Raymond James & Associates's Morphic Holding, Inc. Common Stock position peaked at $380K in Q1 2021.
  • 106 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q2 2021.

Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.